Cerecor Inc (NASDAQ:CERC)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CERC

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CERC

  • Market Cap$355.000m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS15671L1098

Company Profile

Cerecor Inc is a biopharmaceutical company focused on development and commercialization of treatments for rare and orphan diseases. Its rare disease pipeline includes CERC-801, CERC-802 and CERC-803, which are in development for therapies for congenital disorders of glycosylation and CERC-006, an oral mTORC1/2 inhibitor in development for the treatment of complex lymphatic malformations. It is also developing two monoclonal antibodies, CERC-002 and CERC-007. CERC-002 targets the cytokine LIGHT (TNFSF14) and is in clinical development for the treatment of severe pediatric-onset Crohn's disease and COVID-19 acute respiratory distress syndrome.Cerecor Inc is a clinical stage biopharmaceutical company which is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The company owns a right to COMTi platform.

Latest CERC news

Currently there for this company. Visit our news hub for other news .